Approval · Notice of Compliance 276 · 2004
PRAVACHOL: Notice of Compliance 276
Issued March 26, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 276
- Date
- March 26, 2004
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new 80 mg strength and revised dosage recommendations
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRAVACHOL | Not yet assigned | — |
| PRAVACHOL | 02250330 | Cancelled Pre Market |
Medicinal ingredients
- PRAVASTATIN SODIUM 10 MG per TAB
- PRAVASTATIN SODIUM 20 MG per TAB
- PRAVASTATIN SODIUM 40 MG per TAB
- PRAVASTATIN SODIUM 80 MG per TAB